AGL vs. DVA, FMS, SHC, PGNY, INSP, KRTX, MASI, JAZZ, NBIX, and TEVA
Should you be buying agilon health stock or one of its competitors? The main competitors of agilon health include DaVita (DVA), Fresenius Medical Care AG & Co. KGaA (FMS), Sotera Health (SHC), Progyny (PGNY), Inspire Medical Systems (INSP), Karuna Therapeutics (KRTX), Masimo (MASI), Jazz Pharmaceuticals (JAZZ), Neurocrine Biosciences (NBIX), and Teva Pharmaceutical Industries (TEVA). These companies are all part of the "medical" sector.
agilon health vs.
DaVita (NYSE:DVA) and agilon health (NYSE:AGL) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.
DaVita has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, agilon health has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.
In the previous week, DaVita had 10 more articles in the media than agilon health. MarketBeat recorded 16 mentions for DaVita and 6 mentions for agilon health. DaVita's average media sentiment score of 0.87 beat agilon health's score of 0.48 indicating that DaVita is being referred to more favorably in the media.
DaVita has higher revenue and earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.
DaVita presently has a consensus target price of $96.88, indicating a potential downside of 2.30%. agilon health has a consensus target price of $31.13, indicating a potential upside of 50.36%. Given agilon health's stronger consensus rating and higher possible upside, analysts clearly believe agilon health is more favorable than DaVita.
DaVita has a net margin of 4.40% compared to agilon health's net margin of -2.88%. DaVita's return on equity of 72.08% beat agilon health's return on equity.
DaVita received 443 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 61.83% of users gave DaVita an outperform vote while only 60.32% of users gave agilon health an outperform vote.
86.5% of DaVita shares are held by institutional investors. 1.4% of DaVita shares are held by insiders. Comparatively, 3.6% of agilon health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
DaVita beats agilon health on 12 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
agilon health Competitors List
Related Companies and Tools